. Step 34 of 41
Clinical Stem 1
Non-smoking female with a new right upper lobe lung mass and three PET-positive mediastinal lymph nodes

Question 9
What would you do next if the patient wants to be considered for clinical trials using targeted therapy?
A. Discuss the adequacy of the specimen with the pathologist on site prior to requesting molecular tests.

B. Given the scant amount of tissue, order molecular testing without confirming non-squamous non-small cell carcinoma by immunohistochemistry.

C. Wait for final results. After malignancy is confirmed, refer the patient for chemotherapy without ordering molecular testing.

D. Wait for final results. After malignancy is confirmed, initiate discussions about quality of life and refer the patient to a palliative care specialist.
incorrect correct
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology